DBVTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as DBVTF
DBV Technologies S.A.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 16, 2026
$8.97−0.08 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $3.89B
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
DBV Technologies has not reported a dividend
No dividend per share appears in DBV Technologies's annual filings since fiscal 2015.